) Core B, the Nucleic Acid Synthesis and Sequencing Core is critical to the success of each of the projects. The Core, which is situated within the Sydney Kimmel Nucleic Acid Facility, is used on a daily basis by all of the Project leaders and their laboratory staff. Specifically for the Program, because it is involved in sequencing on the order of hundreds of kilobases, the Core will dedicate a full-time research assistant and a sequencing machine for the Program. We have found it an efficient mechanism for the heaviest users of the Facility to work directly with one technician under the supervision of Hannes Alder. Project 2 will require more than 3000 sequencing runs just to complete another 200 kilobases of sequence and not considering sequencing of the multiple inverse PCR products. Projects 1 and 3 will need regular sequencing runs also to characterize mutants, constructs, Fhit interacting gene candidates, genomic clones and PCR products. All the Projects will require numerous oligonucleotides, with Project 2 requiring on the order of 300 in the first year for characterization of the regions of FHIT remaining to be sequenced.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA077738-03
Application #
6570500
Study Section
Subcommittee G - Education (NCI)
Project Start
2002-03-01
Project End
2003-02-28
Budget Start
Budget End
Support Year
3
Fiscal Year
2002
Total Cost
$151,297
Indirect Cost
Name
Thomas Jefferson University
Department
Type
DUNS #
061197161
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Nana-Sinkam, S Patrick; Croce, Carlo M (2014) MicroRNA regulation of tumorigenesis, cancer progression and interpatient heterogeneity: towards clinical use. Genome Biol 15:445
Saldivar, Joshua C; Bene, Jessica; Hosseini, Seyed Ali et al. (2013) Characterization of the role of Fhit in suppression of DNA damage. Adv Biol Regul 53:77-85
Huebner, Kay; Saldivar, Joshua C; Sun, Jin et al. (2011) Hits, Fhits and Nits: beyond enzymatic function. Adv Enzyme Regul 51:208-17
Cirombella, Roberto; Montrone, Giuseppe; Stoppacciaro, Antonella et al. (2010) Fhit loss in lung preneoplasia: relation to DNA damage response checkpoint activation. Cancer Lett 291:230-6
Sun, Jin; Okumura, Hiroshi; Yearsley, Martha et al. (2009) Nit1 and Fhit tumor suppressor activities are additive. J Cell Biochem 107:1097-106
Pichiorri, Flavia; Okumura, Hiroshi; Nakamura, Tatsuya et al. (2009) Correlation of fragile histidine triad (Fhit) protein structural features with effector interactions and biological functions. J Biol Chem 284:1040-9
Ishii, Hideshi; Mimori, Koshi; Ishikawa, Kazuhiro et al. (2008) Fhit-deficient hematopoietic stem cells survive hydroquinone exposure carrying precancerous changes. Cancer Res 68:3662-70
Iliopoulos, Dimitrios; Fabbri, Muller; Druck, Teresa et al. (2007) Inhibition of breast cancer cell growth in vitro and in vivo: effect of restoration of Wwox expression. Clin Cancer Res 13:268-74
Semba, Shuho; Huebner, Kay (2006) Protein expression profiling identifies cyclophilin A as a molecular target in Fhit-mediated tumor suppression. Mol Cancer Res 4:529-38
Semba, Shuho; Han, Shuang-Yin; Qin, Haiyan R et al. (2006) Biological functions of mammalian Nit1, the counterpart of the invertebrate NitFhit Rosetta stone protein, a possible tumor suppressor. J Biol Chem 281:28244-53

Showing the most recent 10 out of 53 publications